OpGen (NSDQ:OPGN) said earlier this month that it priced a $10 million public offering of 25 million units of common stock and warrants at 40¢ apiece.
The molecular diagnostics company said each common warrant has an exercise price of 43¢ per share and expires five years after issuance. The offering is slated to close tomorrow.
Get the full story at our sister site, Drug Delivery Business News.
The post OpGen prices $10m public offering appeared first on MassDevice.